Show simple item record

FieldValueLanguage
dc.contributor.authorSparrow, E.en
dc.contributor.authorWood, J.G.en
dc.contributor.authorChadwick, C.en
dc.contributor.authorNewall, A.T.en
dc.contributor.authorTorvaldsen, S.en
dc.contributor.authorMoen, A.en
dc.contributor.authorTorelli, G.en
dc.date.accessioned2021-02-09T22:29:50Z
dc.date.available2021-02-09T22:29:50Z
dc.date.issued2021en
dc.identifier.urihttps://hdl.handle.net/2123/24486
dc.description.abstractVaccines will be an important element in mitigating the impact of an influenza pandemic. While research towards developing universal influenza vaccines is ongoing, the current strategy for vaccine supply in a pandemic relies on seasonal influenza vaccineen
dc.language.isoenen
dc.rightsOther
dc.subjectCOVID-19en
dc.subjectCoronavirusen
dc.titleGlobal production capacity of seasonal and pandemic influenza vaccines in 2019en
dc.typeArticleen
dc.identifier.doi10.1016/j.vaccine.2020.12.018
dc.relation.otherPATHen
dc.relation.otherBiomedical Advanced Research and Development Authority,BARDAen
dc.relation.otherBiomedical Advanced Research and Development Authority,BARDAen
dc.relation.otherWorld Health Organization,WHOen
usyd.facultyFaculty of Medicine and Health, Sydney Medical Schoolen


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.